Celldex Therapeutics Inc (CLDX)

Finanzdaten der Celldex Therapeutics Inc-Aktie (CLDX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	46.67%0.02	0.02	0.12	-	0.73
	7.48%67.54	73.00	-	-	-
Research and Development	7.48%67.54	73.00	-	-	-
Costs And Expenses	4.51%80.65	84.45	87.27	73.62	64.59
Operating Income/Loss	4.51%-80.62	-84.44	-87.15	-73.62	-63.86
	6.59%-73.50	-78.69	-81.32	-67.04	-56.60
Attributable To Parent	6.59%-73.50	-78.69	-81.32	-67.04	-56.60
Available To Common Stockholders, Basic	6.59%-73.50	-78.69	-81.32	-67.04	-56.60
Basic Average Shares	16.94%77.84	66.57	66.36	0.07	0.07
Diluted Average Shares	16.94%77.84	66.57	66.36	0.07	0.07
Basic Earnings Per Share	20.34%-0.94	-1.18	-1.23	-1.01	-0.85
Diluted Earnings Per Share	20.34%-0.94	-1.18	-1.23	-1.01	-0.85